Cero Therapeutics Holdings
OTC: CEROSouth San Francisco, US · Founded 2021 · Delaware corporation
Founders & leadership
KP
Kristen PierceChief Development Officer
CE
Chris EhrlichInterim Chairman and CEO
AA
Andrew Albert KucharchukChief Financial Officer
RR
Robyn RapaportNamed on SEC filing
Board
BA
Brian AtwoodBoard director
KL
Kathleen LaPorteBoard director
MB
Michael ByrnesBoard director
LR
Lindsey RolfeBoard director
Reported raises · per SEC filings
Form D private placements$16.4M disclosed across 3 rounds · 2024–2025
▶$5MraisedMay 2025 · 5 investors · PharmaceuticalsRule 506(b)
▶$5MraisedMay 2025 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Shami PatelDirector
- Kristen PierceExecutive Officer
- Lindsey RolfeDirector
- Kathleen LaPorteDirector
- Andrew Albert KucharchukExecutive Officer
- Chris EhrlichExecutive Officer, Director
- Michael ByrnesDirector
- Brian G. AtwoodDirector
- Offering amount
- $8M
- Amount sold
- $5M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$1.3MraisedOct 2024 · 13 investors · PharmaceuticalsRule 506(b)
▶$1.3MraisedOct 2024 · 13 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kristen PierceExecutive Officer
- Michael ByrnesDirector
- Brian AtwoodDirector
- Lindsey RolfeDirector
- Chris EhrlichExecutive Officer, Director
- Andrew Albert KucharchukExecutive Officer
- Kathleen LaPorteDirector
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- Minimum investment
- $1K
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$10.2MraisedFeb 2024 · 46 investors · PharmaceuticalsRule 506(b)
▶$10.2MraisedFeb 2024 · 46 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Lindsey RolfeDirector
- Robyn RapaportDirector
- Michael ByrnesDirector
- Brian AtwoodExecutive Officer, Director
- Offering amount
- $10.2M
- Amount sold
- $10.2M
- Sales commissions
- $1.2M
- Proceeds to insiders
- $227.8K
- Placement agents
- J.V.B. Financial Group, LLC
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Cero Therapeutics Holdings raised?
- Cero Therapeutics Holdings has disclosed $16.4M raised across 3 rounds.
- Where is Cero Therapeutics Holdings headquartered?
- Cero Therapeutics Holdings is headquartered in South San Francisco, US.